Tenth Circuit Opinion in PCMA v. Mulready
In an unfortunate – and arguably errant – legal development, the United States Tenth Circuit Court of Appeals on Tuesday issued an unfavorable decision.
In an unfortunate – and arguably errant – legal development, the United States Tenth Circuit Court of Appeals on Tuesday issued an unfavorable decision.
Ruling creates a split in the federal courts that could lead to the Supreme Court.
It is a two-year anniversary that patients and pharmacies can appreciate. With a unanimous decision on December 10, 2020, the U.S. Supreme Court upheld an Arkansas law that confronts the damaging tactics of prescription-drug middlemen known as pharmacy benefit managers (PBMs). NACDS had submitted an amicus brief in this case, Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association (PCMA).
The National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), the Oklahoma Pharmacists Association (OPA) and American Pharmacies (APRx) issued the following joint press release today.
NACDS is hailing a decision by the Eighth Circuit of the U.S. Court of Appeals yesterday which upholds a North Dakota law prioritizing the health and safety of patients by promoting the economic viability of local pharmacies.
Compelling amicus brief demonstrates that the U.S. Supreme Court’s Rutledge decision should be applied in upholding North Dakota law.
NACDS notes that the Supreme Court's ruling also is extremely significant for the residents of approximately 40 other states that have enacted similar laws.
Brief argues for maintaining Supreme Court precedents, reversing Circuit Court decision, and upholding Arkansas law vital for patients, pharmacies
The U.S. Supreme Court will review the Eighth Circuit Court’s decision that put the brakes on Arkansas’ PBM law that would ensure that pharmacy reimbursement rates cover pharmacies’ costs of purchasing drugs.